Brief: T2 Biosystems Announces FDA 510(K) Submission For The T2Biothreat Panel
23/05/2023 13:17
May 23 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS ANNOUNCES FDA 510(K) SUBMISSION FOR THE
T2BIOTHREAT PANEL
* T2 BIOSYSTEMS ANNOUNCES FDA 510(K) SUBMISSION FOR THE
T2BIOTHREAT PANEL
Source text for Eikon: ID:nGNX4tDDRl
Further company coverage: TTOO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor